Warning: file_put_contents(c/960bc82b336f7a07520a437f0349837a.php): Failed to open stream: No space left on device in /home/w/04uk/_____/f.php on line 139
Tamesis Pharma Llp, DE4 4EG Company Information, Office Address, Contact, Directors & Officers, Accounts, Statements and Filing History : UKBizDB.co.uk
UKBizDB.co.uk

TAMESIS PHARMA LLP

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Tamesis Pharma Llp. The company was founded 13 years ago and was given the registration number OC363617. The firm's registered office is in MATLOCK. You can find them at 40 West End, Wirksworth, Matlock, Derbyshire. This company's SIC code is None Supplied.

Company Information

Name:TAMESIS PHARMA LLP
Company Number:OC363617
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:07 April 2011
End of financial year:30 April 2021
Jurisdiction:England - Wales
Industry Codes:
  • None Supplied

Office Address & Contact

Registered Address:40 West End, Wirksworth, Matlock, Derbyshire, DE4 4EG
Country Origin:
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
40, West End, Wirksworth, Matlock, United Kingdom, DE4 4EG

Llp Designated Member07 April 2011Active
40, West End, Wirksworth, Matlock, United Kingdom, DE4 4EG

Llp Designated Member07 April 2011Active

People with Significant Control

Mr Roger James Cassidy
Notified on:06 April 2017
Status:Active
Date of birth:August 1958
Nationality:British
Address:40, West End, Matlock, DE4 4EG
Nature of control:
  • Significant influence or control limited liability partnership

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (1 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (0 months remaining)

Copyright © 2024. All rights reserved.